Fatal blood clot genetic risk breakthrough announcement

Researchers from Leicester and Cambridge lead discovery of genetic markers that identify people at risk of clot formation and heart attack

2010-11-25

(Press-News.org) An international team led by researchers from the Universities of Leicester and Cambridge has announced a breakthrough in identifying people at risk of developing potentially fatal blood clots that can lead to heart attack.

The discovery, published this week (25 November) in the leading haematology journal Blood, is expected to advance ways of detecting and treating coronary heart disease – the most common form of disease affecting the heart and an important cause of premature death.

The research led by Professor Alison Goodall from the University of Leicester and Professor Willem Ouwehand from the University of Cambridge and NHS Blood and Transplant was carried out in collaboration with colleagues at the Wellcome Trust Sanger Institute, University College Dublin, and the University of Leuven, as part of a large programme to discover novel genes regulating platelets; the tiny cells in the blood that stick together to form a blood clot.

Understanding what makes these cells more sticky in some people than others could provide potential therapeutic targets for treatment of cardiovascular disease.

Lead author Professor Goodall, of the Department of Cardiovascular Sciences at the University of Leicester, said: "We have long known that platelet activity and clot formation varied between different people – but we now have identified some of the genetic reasons for this."

Professor Ouwehand said the research had uncovered a new molecule that plays an important role in platelets. He said: "Studies in large number of NHS patients who experienced a heart attack and healthy controls suggests that genetic differences in the gene for this protein slightly modifies the risk for blood clots. This type of study will help us to unravel the complex question why some people have a higher risk of a heart attack than others. One day this type of research may lead to a new generation of drugs that can be used to reduce the risk of this devastating disease."

INFORMATION:

The study was carried out as part of the European Union funded Bloodomics's project.

For interviews contact:
Professor Alison H Goodall, PhD
Department of Cardiovascular Sciences
University of Leicester
Tel: +44(0)116 256 3026/3045
email: ahg5@le.ac.uk

The URL to the paper is: http://bloodjournal.hematologylibrary.org/cgi/content/abstract/116/22/4646
This will go live after 2pm EST (7 GMT) on Thursday November 25

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Growth-factor gel shows promise as hearing-loss treatment

2010-11-25

A new treatment has been developed for sudden sensorineural hearing loss (SSHL), a condition that causes deafness in 40,000 Americans each year, usually in early middle-age. Researchers writing in the open access journal BMC Medicine describe the positive results of a preliminary trial of insulin-like growth factor 1 (IGF1), applied as a topical gel. Takayuki Nakagawa, from Kyoto University, Japan, worked with a team of researchers to test the gel in 25 patients whose SSHL had not responded to the normal treatment of systemic gluticosteroids. He said, "The results indicated ...

Each 5-degree temperature rise boosts kids' hospital admissions for serious injury by 10 percent

2010-11-25

Every 5°C rise in maximum temperature pushes up the rate of hospital admissions for serious injuries among children, reveals one of the largest studies of its kind published online in Emergency Medicine Journal. Conversely, each 5° C drop in the minimum daily temperature boosts adult admissions for serious injury by more than 3%, while snow prompts an 8% rise, the research shows. The authors base their findings on the patterns of hospital treatment for both adults and children in 21 emergency care units across England, belonging to the Trauma Audit and research Network ...

Workplace asthma costs UK at least $158 million a year

2010-11-25

Workplace asthma costs the UK at least £100 million a year, and may be as high as £135 million, reveals research published online in Thorax. An estimated 3,000 new cases of occupational asthma are diagnosed every year in the UK, but the condition is under diagnosed, say the authors. They reviewed published data on the costs of all asthma and workplace asthma, as well as the impact costs. The evidence was then used to calculate the costs of workplace asthma on an individual's ability to work and their wider life, including their use of health services, based on a ...

Epilepsy drugs may not affect IQ of breastfed babies, study says

2010-11-25

New research from the Emory University School of Medicine offers reassurance for nursing mothers with epilepsy. According to a study published in the November 24 online issue of Neurology, the medical journal of the American Academy of Neurology, breastfeeding a baby while taking a seizure medication may have no harmful effect on the child's IQ later in life. "Our results showed no difference in IQ scores between the children who were breastfed and those who were not," says study author Kimford Meador, MD, professor of neurology, Emory University School of Medicine and ...

Jet-lagged and forgetful? It's no coincidence

2010-11-25

Chronic jet lag alters the brain in ways that cause memory and learning problems long after one's return to a regular 24-hour schedule, according to research by University of California, Berkeley, psychologists. Twice a week for four weeks, the researchers subjected female Syrian hamsters to six-hour time shifts – the equivalent of a New York-to-Paris airplane flight. During the last two weeks of jet lag and a month after recovery from it, the hamsters' performance on learning and memory tasks was measured. As expected, during the jet lag period, the hamsters had trouble ...

Being a 'good sport' can be critical to maintaining lifelong physical activity

2010-11-25

Toronto, ON – November 24 – It's never fun riding the bench – but could it also make you less likely to be physically active in the future? That's one of the questions being explored by Mark Eys, an associate professor of kinesiology and physical education at Wilfrid Laurier University and the Canada Research Chair in Group Dynamics and Physical Activity. Eys is presenting his work as part of this week's Canada Research Chairs conference in Toronto. Eys, who also teaches out of the university's psychology department, is studying group cohesion – which, in sporting ...

Diabetes drug could work against Alzheimer's

2010-11-25

Bonn, 24th November 2010. Metformin, a drug used in type 2-diabetes might have the potential to also act against Alzheimer's disease. This has been shown in a study from scientists of the German Center for Neurodegenerative Diseases (DZNE), the University of Dundee and the Max-Planck-Institute for Molecular Genetics. The researchers have found out that the diabetes drug metformin counteracts alterations of the cell structure protein Tau in mice nerve cells. These alterations are a main cause of the Alzheimer's disease. Moreover, they uncovered the molecular mechanism of ...

Female fish -- and humans? -- lose interest when their male loses a slugfest

2010-11-25

You may think of your love for your mate as the noble emotion of a pure heart, but some primitive parts of your brain are taking a decidedly more pragmatic approach to the subject, according to Stanford biologists. In experiments with African cichlid fish, the scientists discovered that when a female shows a preference for a particular male, but then witnesses him losing a fight with another male, her feelings toward him change. Areas of the female's brain associated with anxiety showed increased activity after witnessing an altercation. "It is the same as if a woman ...

New study reveals how cannabis suppresses immune functions

2010-11-25

An international team of immunologists studying the effects of cannabis have discovered how smoking marijuana can trigger a suppression of the body's immune functions. The research, published in the European Journal of Immunology, reveals why cannabis users are more susceptible to certain types of cancers and infections. The team, led by Dr Prakash Nagarkatti from the University of South Carolina, focused their research on cannabinoids, a group of compounds found inside the cannabis plant, including THC (delta-9 tetahydrocannabinol) which is already used for medical ...

When Belgium sneezes, the world catches a cold

2010-11-25

As the eurozone continues to wobble, new analysis of countries' economic interconnectedness finds that some of the countries with the greatest potential to cause a global crash have surprisingly small gross domestic production. Using data from Bureau Van Dijk - the company information and business intelligence provider - to assess the reach and size of different countries' economies, and applying the Susceptible-Infected-Recovered (SIR) model, physicists from universities in Greece, Switzerland and Israel have identified the twelve countries with greatest power to spread ...

LAST 30 PRESS RELEASES:

Evaluating performance and agreement of coronary heart disease polygenic risk scores

Heart failure in zero gravity— external constraint and cardiac hemodynamics

Amid record year for dengue infections, new study finds climate change responsible for 19% of today’s rising dengue burden

New study finds air pollution increases inflammation primarily in patients with heart disease

AI finds undiagnosed liver disease in early stages

The American Society of Tropical Medicine and Hygiene and the Bill & Melinda Gates Foundation announce new research fellowship in malaria genomics in honor of professor Dominic Kwiatkowski